Opioid Stewardship in Cancer: Implementation Strategies
Summary of the Interview Excerpt:
This excerpt features an interview with Matthew D. Clark, PharmD, discussing a new opioid stewardship programme implemented at a cancer institution, despite being exempt from typical opioid regulations. Here’s a breakdown of the key points:
* Motivation for the Program: While not legally required, the team felt a moral and ethical obligation too ensure patient safety regarding opioid prescriptions. A critically important increase in inappropriate opioid-related behaviors, particularly post-pandemic, prompted the creation of a dedicated team.
* Ethical Responsibility: Clark emphasizes the pharmacist’s oath to provide the safest and best care, irrespective of regulatory status.
* Pharmacist’s Role: The pharmacist and their team act as a resource for other healthcare professionals, providing support and developing treatment plans for patients identified as at risk for opioid misuse or actively misusing opioids.
* Impact of Pharmacist Involvement: The presence of the pharmacy team has increased awareness and led to safer opioid prescribing practices. Healthcare providers now proactively seek their assistance with complex cases.
* Novelty of Pharmacy Stewardship: Clark notes that pharmacist involvement in opioid stewardship is a relatively new development.
In essence, the program is driven by a commitment to patient safety and a proactive approach to addressing a growing problem, even in a setting where regulations are less stringent. The pharmacist plays a crucial role in identifying and managing patients at risk.